Longitudinal Analysis of Developmental Delays in Children With Neurofibromatosis Type 1

被引:18
作者
Wessel, Lauren E. [1 ]
Gao, Feng [1 ]
Gutmann, David H. [1 ]
Dunn, Courtney M. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
neurofibromatosis type 1; gross motor; development; fine motor; physical therapy; GROSS MOTOR DEVELOPMENT; NEUROPSYCHOLOGICAL PROFILE; ACADEMIC-PERFORMANCE; COGNITIVE FUNCTION; SURVEILLANCE; DISORDERS; NF1;
D O I
10.1177/0883073812462885
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Children with neurofibromatosis type 1 exhibit a variety of developmental delays. However, there is little information about the progression of these deficits over the course of development. Using the Parents' Evaluation of Developmental Status measurement tool, we assessed 124 infants (0-2 years of age), preschool-age children (3-5 years of age), and school-age children (6-8 years of age) with neurofibromatosis type 1 to define the natural history of delays. School-age children exhibited significantly more areas of delay than infants or preschool-age children. Delays in math, reading, gross motor, fine motor, and self-help development were observed more frequently in older than younger children. Finally, analysis of 43 subjects for whom longitudinal assessments were available revealed that children often migrated between delayed and nondelayed groups in all areas except gross motor development. Based on these findings, we advocate early developmental screening and intervention for this at-risk pediatric population, especially in the area of gross motor function.
引用
收藏
页码:1689 / 1693
页数:5
相关论文
共 27 条
[1]   PEDS: Developmental milestones - An accurate brief tool for surveillance and screening [J].
Brothers, Kyle B. ;
Glascoe, Frances Page ;
Robertshaw, Nicholas S. .
CLINICAL PEDIATRICS, 2008, 47 (03) :271-279
[2]   Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children [J].
Coude, Francois X. ;
Mignot, Claire ;
Lyonnet, Stanislas ;
Munnich, Arnold .
BEHAVIOR GENETICS, 2006, 36 (05) :660-664
[3]  
Council on ChildrenWith Disabilities
[4]  
Section on Developmental Behavioral Pediatrics
[5]  
Bright Futures Steering Committee
[6]  
Medical Home Initiatives for ChildrenWith Special Needs Project Advisory Committee, 2006, PEDIATRICS, V118, P405
[7]  
Dilts CV, 1996, J DEV BEHAV PEDIATR, V17, P229
[8]  
Guralnick M.J., 1997, EFFECTIVENESS EARLY
[9]   The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [J].
Gutmann, DH ;
Aylsworth, A ;
Carey, JC ;
Korf, B ;
Marks, J ;
Pyeritz, RE ;
Rubenstein, A ;
Viskochil, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :51-57
[10]   Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder [J].
Hyman, Shelley L. ;
Shores, E. Arthur ;
North, Kathryn N. .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (12) :973-977